Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Event will feature David Lassen, chief clinical officer

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Annual conference features presentations, panels, discussions and networking

Notice of Privacy Practices To allow a family member or agent to contact Prime on your behalf, please print, complete and return the release form below: Authorization for Release of Information |...

Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...

PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: July 2025 Prime Careers Spotlight: July 2025 Check out our latest job openings. Together, we can help make...

Dinesh Kandanchatha joined the organization July 1.

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

Managed Markets Insight & Technology (MMIT)

publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...

publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...

Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...

Commercial formularies Breadcrumb Home Other Navigation Pharmacy + Providers Commercial Formularies PrimeChoice Accord Formulary PrimeChoice Accord Formulary Updates NetResults A-Series...

Effective: January 2021 Terms of use IF YOU ARE EXPERIENCING A MEDICAL EMERGENCY, DIAL 911 AND/OR SEEK IMMEDIATE ATTENTION FROM A HEALTH CARE PROVIDER. THIS WEBSITE DOES NOT PROVIDE MEDICAL...

Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Drug Approvals: October 2024 PUBLICATIONS Drug Approvals: October 2024 This monthly update of United States (U.S.) Food and Drug...

Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.

publications Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches March 26, 2025 Specialty New drugs March...

Pharmacy Times

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

publications Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches April 29, 2025 Specialty New drugs March...

Event features Prime's Health Outcomes team

Check inquiry Breadcrumb Home Other Navigation Pharmacy + Providers Check inquiry This form is specifically used to request a check reissue. For remittance requests, please use the following link:...

Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...

Drug Approvals Monthly Update: October 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Disclaimer THIS WEBSITE IS AN OPTIONAL RESOURCE FOR HEALTH CARE PROVIDERS ONLY. IF YOU ARE NOT A HEALTH CARE PROVIDER OR AUTHORIZED PROFESSIONAL USER, YOU ARE NOT TO USE THIS SITE AT ALL AND ARE...

Prime Perspective Breadcrumb Home Other Navigation Pharmacy + Providers Prime Perspective Pharmacy newsletter from Prime Therapeutics that provides information and updates about Prime services....

publications Fall 2024 Prime Therapeutics Report October 21, 2024 Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on...

The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...

cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...

Cover image for Drug approvals Critical updates in an ever-changing environment  Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...

Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...

Becker’s Payer Issues

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Drug Approvals Quarterly Update: October 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

Recognition benchmarks disability workplace inclusion against other companies

Perspectives Expert Clinical Network Insights: June 2024 A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that...

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe